These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [The effect of carbocromen on the ST segment of the epicardial electrocardiogram in a model of intermitting myocardial ischemia (author's transl)]. Sirbulescu R; Scholtholt J; Nitz RE; Kunath B Arzneimittelforschung; 1976 Feb; 26(2):204-8. PubMed ID: 820356 [TBL] [Abstract][Full Text] [Related]
26. [Letter: Anti-anginous effect of intensain]. Dtsch Med Wochenschr; 1976 Mar; 101(11):429. PubMed ID: 1253708 [No Abstract] [Full Text] [Related]
27. Acute effects of the coronary vasodilator carbocromen on myocardial oxygen consumption, substrate uptake and mechanical performance in intact dogs. Vik-Mo H; Mjøs OD; Smiseth O; Riemersma RA; Oliver MF Arzneimittelforschung; 1981; 31(7):1088-91. PubMed ID: 7196756 [TBL] [Abstract][Full Text] [Related]
28. [Controlled clinical tests of the coronary agent, Carduben]. Brinkmann O; Haase W Med Welt; 1972 Mar; 23(14):500-2. PubMed ID: 4555294 [No Abstract] [Full Text] [Related]
29. [The effects of oral carbocromen on the therapeutic and toxic effects of digitalis]. Scholtholt J; Fiedler VB; Göbel H Arzneimittelforschung; 1980; 30(1):9-12. PubMed ID: 7370078 [TBL] [Abstract][Full Text] [Related]
30. [Clinical evaluation of Intenkordin]. Markiewicz M; Korolko A; Hruczkowska E Pol Tyg Lek; 1972 May; 27(21):796-8. PubMed ID: 5028365 [No Abstract] [Full Text] [Related]
31. [Cycloergometric evaluation of the continuous use of verapamil 360 mg/per day in chronic coronary insufficiency]. Figueira RH; Bozza AE; Guimarães F; Terra LS; Silva O; Pereira E; Maiolino E; Dohmann HJ Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():55-8. PubMed ID: 329808 [No Abstract] [Full Text] [Related]
33. [Results of a double blind study with Segontin-Digoxin in coronary heart disease (author's transl)]. Nossen J MMW Munch Med Wochenschr; 1977 Feb; 119(5):159-62. PubMed ID: 402569 [TBL] [Abstract][Full Text] [Related]
34. [Influence of Carbocromen on A-V-conduction and refractory period. Electrophysiological study with His-bundle-electrography in experimental animals (author's transl)]. Djonlagić H; Diederich KW Arzneimittelforschung; 1981; 31(12):2072-4. PubMed ID: 7199301 [TBL] [Abstract][Full Text] [Related]
35. [Controlled therapy using coumarins and chlorambucil in endo-and extracapillary focal glomerulonephritis]. Mota Hernández F; Velásquez Jones L; Gordillo Paniagua G Bol Med Hosp Infant Mex; 1976; 33(4):821-9. PubMed ID: 782482 [No Abstract] [Full Text] [Related]
36. [Influence of carbocromen and of other coronary dilator agents on the blood flow of a myocardial ischemic area]. Faucon G; Ollagnier M; de Claviere M; Kofman J; Evreux JC Therapie; 1975; 30(2):185-95. PubMed ID: 1162641 [No Abstract] [Full Text] [Related]
37. [Biochemical mechanisms of action of coronarodilating agents (review of the literature)]. Chekman IS; Kazak LI Vrach Delo; 1976; (5):23-9. PubMed ID: 9729 [No Abstract] [Full Text] [Related]
38. [Cycloergometric evaluation of the effects of verapamil in chronic coronary insufficiency]. Meneghelo RS; Duprat R; Batlouni M; Severino CA; Armaganijan D; Magalhães HM; Feher J Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():59-63. PubMed ID: 329809 [No Abstract] [Full Text] [Related]
39. [Effects of oxandrolone in dyslipidemias]. Pereira FA; Gottschall CA; Rodrigues R Arq Bras Cardiol; 1975 Dec; 28(6):661-6. PubMed ID: 766738 [No Abstract] [Full Text] [Related]
40. [Studies on inhibition of platelet aggregation by carbocromen (author's transl)]. Resag K; Melzer G; Nitz RE Arzneimittelforschung; 1976 Feb; 26(2):209-13. PubMed ID: 947200 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]